Entity
Description
  • Value proposition

    Leading patient advocacy organization working to eliminate the challenges of rare disease. #CareAboutRARE #RareDisease

    Empowering the Next Generation Rare Disease Advocate.

    Global Genes and RARE-X officially merged into one organization December 2022 under the name Global Genes. Both organizations have been working toward the goal of empowering the next generation advocate both through their individual initiatives and their strategic partnership announced in 2021. In fact, RARE-X was born out of Global Genes after discussions with advocacy leaders, board members, partners, patients, and care partners, addressing a significant gap in access to tools, technology, and infrastructure.

    We're Hiring! Check out our open positions at https://globalgenes.org/about-us/career-opportunities/


    Rare Disease Awareness, Public and Physician Education, Supporting Research Initiatives, Patient Advocacy, Rare Disease, Undiagnosed Patient Program, Education, Genetics, Events, Programs, Resources, Connect, Empower, Inspire, FoundationAlliances, and CorporateAlliances

Corporate interactions BETA
Corporate TypeTweets Articles
Roche
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Other

29 Sep 2023


Amazon
Amazon
IT services, Consumer Electronics, Software Development
Amazon
IT services, Consumer Electronics, Software Development
Other

14 Feb 2023


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

16 Dec 2023


Similar entities
Loading...
Loading...
Social network dynamics